Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • The effect of omalizumab treat...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
The effect of omalizumab treatment on severe allergic asthma and allergic comorbidities: real-life experience from the Czech Anti-IgE Registry

The effect of omalizumab treatment on severe allergic asthma and allergic comorbidities: real-life experience from the Czech Anti-IgE Registry

Bibliographic Details
Main Authors: Beáta Hutyrová, Jaromir Bystroň, Czech Anti-IgE Registry collaborators
Format: Article
Language:English
Published: Termedia Publishing House 2018-07-01
Series:Advances in Dermatology and Allergology
Subjects:
omalizumab
severe allergic asthma
allergic diseases
Online Access:https://www.termedia.pl/The-effect-of-omalizumab-treatment-on-severe-allergic-asthma-and-allergic-comorbidities-real-life-experience-from-the-Czech-Anti-IgE-Registry,7,33351,1,1.html
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.termedia.pl/The-effect-of-omalizumab-treatment-on-severe-allergic-asthma-and-allergic-comorbidities-real-life-experience-from-the-Czech-Anti-IgE-Registry,7,33351,1,1.html

Similar Items

  • Effect of individual allergen sensitization on omalizumab treatment outcomes in patients with severe allergic asthma determined using data from the Czech Anti-IgE Registry
    by: Petr Vaník, et al.
    Published: (2020-09-01)
  • Omalizumab Effectiveness in Severe Allergic Asthma with Multiple Allergic Comorbidities: A Post-Hoc Analysis of the STELLAIR Study
    by: Just J, et al.
    Published: (2021-09-01)
  • Omalizumab Treatment in Patients with Severe Allergic Asthma
    by: Tuğba Songül Tat, et al.
    Published: (2017-09-01)
  • 4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
    by: S. M. Snelder, et al.
    Published: (2017-07-01)
  • Patient characteristics that can predict response to omalizumab an (Anti-IgE Antibody) for achieving better control of asthmatic patients
    by: Nancy M. Abdelaty
    Published: (2012-07-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...